查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760494

2025年全球乳癌筛检市场报告

Breast Cancer Screening Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年乳癌筛检市场规模将强劲成长，2029年将达到34.6亿美元，年复合成长率（CAGR）为8.3%。预测期内的预期成长与乳癌筛检率上升、政府措施加强、医疗保健支出增加、行动筛检单位扩张以及女性人口成长有关。预计这段时期的主要趋势包括诊断影像技术的进步、非侵入性筛检技术的兴起、基因检测的进步、基因组检测的创新以及行动筛检解决方案的开发。

乳癌发生率的上升预计将推动乳癌筛检检测市场的成长。乳癌是指乳腺组织细胞异常且不受控制地增殖，这些细胞可能发展成肿瘤并转移到身体其他部位。乳癌患者的增加是由于全球人口老化，因为患病风险随着年龄的增长而显着增加。乳癌筛检检测对于及早发现乳癌、改善治疗效果和降低死亡率至关重要。例如，2025 年 3 月，美国非营利组织 Breastcancer.org 预测，2025 年将有约 316,950 名女性被诊断出患有侵袭性乳癌，同时有 59,080 例导管原位癌 (DCIS)。此外，2024 年 12 月，加拿大公共卫生署报告称，2022 年加拿大预计将有 28,600 名女性被诊断出患有乳癌，导致 5,500 人死亡。因此，乳癌盛行率的上升促进了乳癌筛检测试市场的扩张。

乳癌筛检领域的主要企业正优先开发行动筛检设备等尖端解决方案，以提高可近性、提高早期发现率，并将服务扩展到医疗资源匮乏和偏远地区。这些行动装置配备了乳房X光摄影等影像技术，旨在为医疗资源匮乏的地区提供现场乳癌筛检。例如，2024 年 9 月，印度製药公司 Granules India Ltd. 推出了「乳房健康快车」（Breast Health Express），以在医疗资源匮乏的地区推广乳癌筛检。该设备配备先进的乳房X光摄影和超音波系统，可在移动中提供高品质的筛检。该倡议旨在为农村和服务匮乏的地区提供早期检测服务，帮助这些地区的女性获得关键的医疗保健服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球乳癌筛检测试的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球乳癌筛检测试市场：成长率分析
  • 全球乳癌筛检检测市场表现：规模与成长，2019-2024
  • 全球乳癌筛检市场预测：规模与成长，2024-2029，2034
  • 全球乳癌筛检检测总目标市场（TAM）

第六章市场区隔

  • 全球乳癌筛检检测市场（依诊断检测类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 血液标记检测
  • 影像检查
  • 基因检测
  • 免疫组织化学
  • 全球乳癌筛检检测市场风险等级、表现及预测（2019-2024、2024-2029、2034）
  • 高危险群
  • 中度风险族群
  • 平均风险族群
  • 全球乳癌筛检检测市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 癌症研究所
  • 实验室
  • 全球乳癌筛检检测市场：血液标记检测细分（按类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 循环性肿瘤细胞（CTCS）检测
  • 基因表现测试
  • 循环肿瘤DNA（CTDNA）检测
  • 蛋白质体生物标记检测
  • 全球乳癌筛检检测市场：影像检查细分（按类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 乳房X光检查
  • 磁振造影筛检测试
  • 分子乳房摄影
  • 正子断层扫描
  • 超音波
  • 全球乳癌筛检检测市场：基因检测细分（按类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 萤光原位杂合反应
  • HER基因检测
  • 全球乳癌筛检检测市场：免疫组织化学（IHC）检测细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 雌激素受体 (ER) 测试
  • Ki-67增殖标记检测
  • 孕酮受体（Pr）测试
  • Her2 或 Neu 侦测

第七章 区域和国家分析

  • 全球乳癌筛检市场各地区、表现及预测（2019-2024、2024-2029、2034 ）
  • 全球乳癌筛检市场（依国家/地区筛检）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 乳癌筛检检测市场：竞争格局
  • 乳癌筛检市场：公司筛检
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Quest Diagnostics Incorporated
  • Hologic Inc.
  • Hitachi High-Tech Corporation
  • Exact Sciences Corporation
  • Natera Inc.
  • Myriad Genetics Inc.
  • Canon Medical Systems Corporation
  • Provista Diagnostics Inc.
  • POC Medical Systems Inc.
  • Niramai Health Analytix Pvt. Ltd.
  • Kheiron Medical Technologies Limited
  • UE LifeSciences Inc.
  • Dxcover Limited

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年乳癌筛检市场：提供新机会的筛检
  • 2029年乳癌筛检检测市场：细分领域带来新机会
  • 2029筛检乳癌市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35371

A breast cancer screening test is a medical procedure or diagnostic method designed to detect breast cancer at an early stage, often before any symptoms develop. The main objective of screening is to discover cancer when it is most treatable, thereby potentially lowering mortality rates and enhancing patient outcomes. Early diagnosis through breast cancer screening enables timely treatment and leads to a more favorable prognosis.

The primary types of diagnostic tests used in breast cancer screening include blood marker tests, imaging tests, genetic tests, and immunohistochemistry tests. Blood marker tests identify and quantify specific substances in the blood to support disease detection, monitoring, or risk evaluation. Different levels of risk-high-risk, moderate-risk, and average-risk populations-are considered, and the tests are utilized by various end users, including hospitals, diagnostic centers, cancer institutes, and research laboratories.

The breast cancer screening tests market research report is one of a series of new reports from The Business Research Company that provides breast cancer screening tests market statistics, including the breast cancer screening tests industry's global market size, regional shares, competitors with the breast cancer screening tests market share, detailed breast cancer screening tests market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer screening tests market. This breast cancer screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The breast cancer screening test market size has grown strongly in recent years. It will grow from $2.31 billion in 2024 to $2.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be credited to enhanced reimbursement policies, a stronger emphasis on preventive healthcare, increased health awareness, greater investment in research and development, and heightened awareness regarding early detection.

The breast cancer screening test market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be linked to the rising incidence of breast cancer, increased government initiatives, growing healthcare spending, the expansion of mobile screening units, and a rise in the female population. Key trends expected during this period include technological advancements in imaging, the emergence of non-invasive screening techniques, progress in genetic testing, innovations in genomic testing, and the development of mobile screening solutions.

The increasing incidence of breast cancer is anticipated to drive the growth of the breast cancer screening test market. Breast cancer involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop into a tumor and potentially spread to other body parts. The rise in breast cancer cases is attributed to the aging global population, as older age significantly raises the risk of developing the disease, and longer life expectancies mean a greater number of individuals are at risk. Screening tests for breast cancer are essential for identifying the disease in its early stages, thereby improving treatment outcomes and lowering mortality rates. For example, in March 2025, Breastcancer.org, a nonprofit organization based in the US, projected that approximately 316,950 women would be diagnosed with invasive breast cancer in 2025, along with 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Additionally, in December 2024, the Public Health Agency of Canada reported that an estimated 28,600 women in Canada were expected to be diagnosed with breast cancer in 2022, with 5,500 fatalities anticipated. As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast cancer screening test market.

Leading companies in the breast cancer screening test sector are prioritizing the development of cutting-edge solutions such as mobile screening units to improve accessibility, increase early detection, and extend services to underserved or remote regions. These mobile units are transportable facilities equipped with diagnostic imaging technologies like mammography, designed to deliver on-site breast cancer screening in areas lacking adequate healthcare access. For instance, in September 2024, Granules India Ltd., a pharmaceutical company based in India, introduced the Breast Health Express to promote breast cancer screening in disadvantaged communities. Outfitted with advanced mammography and ultrasound systems, the unit facilitates quality screenings while on the move. This initiative aims to bring early detection services to rural and underserved areas, helping to ensure access to critical healthcare for women in these regions.

In August 2024, Hitachi High-Tech Corporation, a Japan-based producer of electronic and electrical equipment, entered into a strategic alliance with Gencurix Inc. for an undisclosed amount. Through this collaboration, Hitachi seeks to utilize its knowledge in in vitro diagnostics and digital technologies to create accurate and efficient molecular diagnostics for cancer. Gencurix Inc., headquartered in South Korea, specializes in breast cancer testing solutions.

Major players in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., POC Medical Systems Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., Dxcover Limited.

North America was the largest region in the breast cancer screening test market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in breast cancer screening test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the breast cancer screening test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The breast cancer screening test market consists of revenues earned by entities by providing services such as early detection, risk assessment, and tumor detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast cancer screening test market also consists of sales of products including ultrasound equipment, screening software, and breast self-examination kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Cancer Screening Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on breast cancer screening test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast cancer screening test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The breast cancer screening test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Test Type: Blood Marker Test; Imaging Test; Genetic Test; Immunohistochemistry Test
  • 2) By Risk Level: High-risk Population; Moderate-risk Population; Average-risk Population
  • 3) By End User: Hospitals; Diagnostic Centres; Cancer Institutes; Research Laboratories

Subsegments

  • 1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test; Gene Expression Profiling Test; Circulating Tumor Dna (Ctdna) Test; Proteomic Biomarker Test
  • 2) By Imaging Test: Mammography; Magnetic Resonance Imaging Screening Test; Molecular Breast Imaging Test; Positron Emission Tomograph Scan; Ultrasound
  • 3) By Genetic Test: Fluorescence In Situ Hybridization; Her Gene Test
  • 4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test; Ki-67 Proliferation Marker Test; Progesterone Receptor (Pr) Test; Her2 Or Neu Test
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; Fujifilm Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Breast Cancer Screening Test Market Characteristics

3. Breast Cancer Screening Test Market Trends And Strategies

4. Breast Cancer Screening Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Breast Cancer Screening Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Breast Cancer Screening Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Breast Cancer Screening Test Market Growth Rate Analysis
  • 5.4. Global Breast Cancer Screening Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Breast Cancer Screening Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Breast Cancer Screening Test Total Addressable Market (TAM)

6. Breast Cancer Screening Test Market Segmentation

  • 6.1. Global Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Marker Test
  • Imaging Test
  • Genetic Test
  • Immunohistochemistry Test
  • 6.2. Global Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-risk Population
  • Moderate-risk Population
  • Average-risk Population
  • 6.3. Global Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centres
  • Cancer Institutes
  • Research Laboratories
  • 6.4. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Blood Marker Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Circulating Tumor Cells (Ctcs) Test
  • Gene Expression Profiling Test
  • Circulating Tumor Dna (Ctdna) Test
  • Proteomic Biomarker Test
  • 6.5. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Imaging Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammography
  • Magnetic Resonance Imaging Screening Test
  • Molecular Breast Imaging Test
  • Positron Emission Tomograph Scan
  • Ultrasound
  • 6.6. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Genetic Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescence In Situ Hybridization
  • Her Gene Test
  • 6.7. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Immunohistochemistry (Ihc) Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Estrogen Receptor (Er) Test
  • Ki-67 Proliferation Marker Test
  • Progesterone Receptor (Pr) Test
  • Her2 Or Neu Test

7. Breast Cancer Screening Test Market Regional And Country Analysis

  • 7.1. Global Breast Cancer Screening Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Breast Cancer Screening Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Breast Cancer Screening Test Market

  • 8.1. Asia-Pacific Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Breast Cancer Screening Test Market

  • 9.1. China Breast Cancer Screening Test Market Overview
  • 9.2. China Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Breast Cancer Screening Test Market

  • 10.1. India Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Breast Cancer Screening Test Market

  • 11.1. Japan Breast Cancer Screening Test Market Overview
  • 11.2. Japan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Breast Cancer Screening Test Market

  • 12.1. Australia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Breast Cancer Screening Test Market

  • 13.1. Indonesia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Breast Cancer Screening Test Market

  • 14.1. South Korea Breast Cancer Screening Test Market Overview
  • 14.2. South Korea Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Breast Cancer Screening Test Market

  • 15.1. Western Europe Breast Cancer Screening Test Market Overview
  • 15.2. Western Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Breast Cancer Screening Test Market

  • 16.1. UK Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Breast Cancer Screening Test Market

  • 17.1. Germany Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Breast Cancer Screening Test Market

  • 18.1. France Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Breast Cancer Screening Test Market

  • 19.1. Italy Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Breast Cancer Screening Test Market

  • 20.1. Spain Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Breast Cancer Screening Test Market

  • 21.1. Eastern Europe Breast Cancer Screening Test Market Overview
  • 21.2. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Breast Cancer Screening Test Market

  • 22.1. Russia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Breast Cancer Screening Test Market

  • 23.1. North America Breast Cancer Screening Test Market Overview
  • 23.2. North America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Breast Cancer Screening Test Market

  • 24.1. USA Breast Cancer Screening Test Market Overview
  • 24.2. USA Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Breast Cancer Screening Test Market

  • 25.1. Canada Breast Cancer Screening Test Market Overview
  • 25.2. Canada Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Breast Cancer Screening Test Market

  • 26.1. South America Breast Cancer Screening Test Market Overview
  • 26.2. South America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Breast Cancer Screening Test Market

  • 27.1. Brazil Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Breast Cancer Screening Test Market

  • 28.1. Middle East Breast Cancer Screening Test Market Overview
  • 28.2. Middle East Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Breast Cancer Screening Test Market

  • 29.1. Africa Breast Cancer Screening Test Market Overview
  • 29.2. Africa Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Breast Cancer Screening Test Market Competitive Landscape And Company Profiles

  • 30.1. Breast Cancer Screening Test Market Competitive Landscape
  • 30.2. Breast Cancer Screening Test Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Breast Cancer Screening Test Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips NV
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Hologic Inc.
  • 31.5. Hitachi High-Tech Corporation
  • 31.6. Exact Sciences Corporation
  • 31.7. Natera Inc.
  • 31.8. Myriad Genetics Inc.
  • 31.9. Canon Medical Systems Corporation
  • 31.10. Provista Diagnostics Inc.
  • 31.11. POC Medical Systems Inc.
  • 31.12. Niramai Health Analytix Pvt. Ltd.
  • 31.13. Kheiron Medical Technologies Limited
  • 31.14. UE LifeSciences Inc.
  • 31.15. Dxcover Limited

32. Global Breast Cancer Screening Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Breast Cancer Screening Test Market

34. Recent Developments In The Breast Cancer Screening Test Market

35. Breast Cancer Screening Test Market High Potential Countries, Segments and Strategies

  • 35.1 Breast Cancer Screening Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Breast Cancer Screening Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Breast Cancer Screening Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer